Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cancer Science
|
January 6, 2010
Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147
Pu Zhao, Wei Zhang, Juan Tang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 24, 2021
A TTP-incorporated scoring model for predicting mortality of solid tumor patients with bloodstream infection caused by Escherichia coli
Qing Zhang, Hao-Yang Gao, Ding Li, et al.
Journal of Cellular and Molecular Medicine
|
July 16, 2010
Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
Ling-Min Kong, Cheng-Gong Liao, Liang Chen, et al.
Hybridoma (2005)
|
May 18, 2006
Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G/CD147 extracellular domain
Li Wang, Xiao-Ming Ku, Yu Li, et al.
International Journal of Biological Sciences
|
January 5, 2026
Erratum: Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma: Erratum
Bo Wang, Fang-Zheng Qi, Ping Chen, et al.
International Journal of Biological Sciences
|
March 14, 2024
Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
Bo Wang, Fang-Zheng Qi, Ping Chen, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2011
HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells
Pu Zhao, Wei Zhang, Shi-Jie Wang, et al.
Medcomm
|
March 12, 2024
Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
Fang-Zheng Qi, Hui-Shan Su, Bo Wang, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2007
A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation
Jing Xu, Zhong-Yang Shen, Xin-Guo Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2006
Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials
Zhi-Nan Chen, Li Mi, Jing Xu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cancer Science
|
January 6, 2010
Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147
Pu Zhao, Wei Zhang, Juan Tang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 24, 2021
A TTP-incorporated scoring model for predicting mortality of solid tumor patients with bloodstream infection caused by Escherichia coli
Qing Zhang, Hao-Yang Gao, Ding Li, et al.
Journal of Cellular and Molecular Medicine
|
July 16, 2010
Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
Ling-Min Kong, Cheng-Gong Liao, Liang Chen, et al.
Hybridoma (2005)
|
May 18, 2006
Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G/CD147 extracellular domain
Li Wang, Xiao-Ming Ku, Yu Li, et al.
International Journal of Biological Sciences
|
January 5, 2026
Erratum: Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma: Erratum
Bo Wang, Fang-Zheng Qi, Ping Chen, et al.
International Journal of Biological Sciences
|
March 14, 2024
Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
Bo Wang, Fang-Zheng Qi, Ping Chen, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2011
HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells
Pu Zhao, Wei Zhang, Shi-Jie Wang, et al.
Medcomm
|
March 12, 2024
Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
Fang-Zheng Qi, Hui-Shan Su, Bo Wang, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2007
A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation
Jing Xu, Zhong-Yang Shen, Xin-Guo Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2006
Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials
Zhi-Nan Chen, Li Mi, Jing Xu, et al.
Page
of 2